TIG Advisors LLC’s Gilead Sciences GILD Stock Holding History

TIG Advisors LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,992	Closed	-$631K	–	216
2020 Q3	$631K	Buy	+9,992	New	+$693K	0.03%	100

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TIG Advisors LLC's GILD Position: Q4 2020 in Review

TIG Advisors LLC sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 9,992 shares — an estimated $631K sold.

TIG Advisors LLC first reported a position in GILD in Q3 2020 and held it in 1 quarter. The position peaked at $631K in Q3 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

TIG Advisors LLC reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
TIG Advisors LLC sold 9,992 Gilead Sciences shares in Q4 2020, an estimated $631K.
TIG Advisors LLC first reported a position in Gilead Sciences in Q3 2020 and held it in 1 quarter.
TIG Advisors LLC's Gilead Sciences position peaked at $631K in Q3 2020.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on TIG Advisors LLC's 13F filing for Q4 2020, filed 16 Feb 2021.